Chemomab Therapeutics (CMMB) Payables (2011 - 2026)
Chemomab Therapeutics (CMMB) recorded Payables of $257,000 in Q2 2026, down 32.0% from $378,000 a year earlier but up 26.0% from the prior quarter.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Payables (2011 - 2026) Analysis & Trends
At the end of FY2025, Chemomab Therapeutics reported Payables of $485,000, down 23.4% from FY2024.
- Annual Payables has a five-year compound annual growth rate of 39.1% (FY2020 to FY2025).
- Across earlier years, Payables came in at $633,000 in FY2024 (+22.7%), $516,000 in FY2023 (-69.4%), $1.69 million in FY2022 (+26.3%) and $1.34 million in FY2021.
- Quarterly Payables has ranged from $194,000 in Q3 2025 to $2.35 million in Q2 2023 over the past five years.
- On a year-over-year basis, Payables has declined for six consecutive quarters, with an average decline of 32.6% over the last eight quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 203.6% in Q2 2022, against a decline of 76.2% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $204,000 (Q1 2026), $485,000 (Q4 2025) and $194,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Chemomab Therapeutics | 7.65 Mn | -27.50 Mn | - | 257,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 257,000.00 |
| Mar 31, 2026 | 204,000.00 |
| Dec 31, 2025 | 485,000.00 |
| Sep 30, 2025 | 194,000.00 |
| Jun 30, 2025 | 378,000.00 |
| Mar 31, 2025 | 490,000.00 |
| Dec 31, 2024 | 633,000.00 |
| Sep 30, 2024 | 386,000.00 |
| Jun 30, 2024 | 1.11 Mn |
| Mar 31, 2024 | 527,000.00 |
| Dec 31, 2023 | 516,000.00 |
| Sep 30, 2023 | 731,000.00 |
| Jun 30, 2023 | 2.35 Mn |
| Mar 31, 2023 | 2.22 Mn |
| Dec 31, 2022 | 1.69 Mn |
| Sep 30, 2022 | 1.25 Mn |
| Jun 30, 2022 | 1.43 Mn |
| Mar 31, 2022 | 1.49 Mn |
| Dec 31, 2021 | 1.34 Mn |
| Sep 30, 2021 | 481,000.00 |
API Access
Chemomab Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();